Premium
Catechol‐bearing imidazolium and benzimidazolium chlorides as promising antimicrobial agents
Author(s) -
Karataş Mert O.,
Günal Selami,
Mansur Ahmet,
Alıcı Bülent,
Özdemir İsmail
Publication year - 2020
Publication title -
archiv der pharmazie
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.468
H-Index - 61
eISSN - 1521-4184
pISSN - 0365-6233
DOI - 10.1002/ardp.202000013
Subject(s) - candida albicans , enterococcus faecalis , antimicrobial , chemistry , staphylococcus aureus , candida glabrata , catechol , klebsiella pneumoniae , microbiology and biotechnology , acinetobacter baumannii , pseudomonas aeruginosa , escherichia coli , candida dubliniensis , nuclear chemistry , bacteria , organic chemistry , corpus albicans , biochemistry , biology , genetics , gene
Catechol‐containing imidazolium (four) and benzimidazolium chlorides (eight) were synthesized to evaluate their antimicrobial properties. All the compounds were fully characterized using 1 H and 13 C nuclear magnetic resonance, liquid chromatography–mass spectrometry, infrared spectroscopic methods, and elemental analyses. Antimicrobial activities of the compounds were tested against the bacteria Escherichia coli , Pseudomonas aeruginosa , Acinetobacter baumannii , Klebsiella pneumoniae , Staphylococcus aureus , methicillin‐resistant S. aureus (MRSA), Enterococcus faecalis , and the fungal strains Candida albicans and Candida glabrata , and promising results were achieved. The two most important benzyl‐substituted benzimidazolium chlorides, 3l and 3k , showed comparable activity to vancomycin against MRSA.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom